APA (7th ed.) Citation

Ye, Q., Wang, H., Xia, X., Zhou, C., Liu, Z., Xia, Z., . . . He, Y. (2020). Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: Structured summary of a study protocol for a randomized controlled trial (Phase I / II). Current controlled trials in cardiovascular medicine, 21(1), 520-4. https://doi.org/10.1186/s13063-020-04380-5

Chicago Style (17th ed.) Citation

Ye, Qingsong, et al. "Safety and Efficacy Assessment of Allogeneic Human Dental Pulp Stem Cells to Treat Patients with Severe COVID-19: Structured Summary of a Study Protocol for a Randomized Controlled Trial (Phase I / II)." Current Controlled Trials in Cardiovascular Medicine 21, no. 1 (2020): 520-4. https://doi.org/10.1186/s13063-020-04380-5.

MLA (9th ed.) Citation

Ye, Qingsong, et al. "Safety and Efficacy Assessment of Allogeneic Human Dental Pulp Stem Cells to Treat Patients with Severe COVID-19: Structured Summary of a Study Protocol for a Randomized Controlled Trial (Phase I / II)." Current Controlled Trials in Cardiovascular Medicine, vol. 21, no. 1, 2020, pp. 520-4, https://doi.org/10.1186/s13063-020-04380-5.